Michael P. Dube

Michael P. Dube

Vice President, Chief Accounting Officer, Former Interim Principal Financial OfficeratIntellia Therapeutics· In the 2024 proxy

Pay in FY2024Intellia Therapeutics stock -61.8% the same year

Michael P. Dube was paid $1.3M in FY2024 (Dec). Intellia Therapeutics stock fell 61.8% that year.

Pay$100 in the stock at the end of FY23 → $38
Pay is from the Summary Compensation Table of each Intellia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Intellia TherapeuticsPublic company · 2 yr
    • Vice President, Chief Accounting Officer, Former Interim Principal Financial Officer2024 – Present · 2 yrStock in role -59%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?